Today, shares of Medicenna Therapeutics Corp opened at $2.33 and closed at $2.38. It traded at a low of $2.33 to a high of $2.48.

Shares advanced 3.03% from the previous day's close of $2.31.

During the day across North America, the TSX Composite closed 0.06% at 21728.55, the S&P 500 closed -0.34% at 5018.39, the Dow Jones Industrial Average closed 0.23% at 37903.29 and the Nasdaq Composite closed -0.33% at 15605.48.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

A total of 68,688 shares was traded during the session, with total trades of 146, while having an average volume of 247,643 over 5 days.

The TSX market on the whole today saw 3,697 price advancers against 1,526 declines and 95 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.68 (April 29,2024) and low as $0.22 (November 01,2023). Moreover, the shares have risen 114.41 percent in the last 12 months, while they have risen 466.67% since the start of 2024.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $172.74 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Medicenna Therapeutics Corp's average recommendation is "Strong Buy" based on 2.00 analysts according to Zacks. Currently, there are 2 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..